post dural puncture headache. Other reaction to spinal and lumbar puncture
Conditions
Interventions
Intervention 1: Intervention: patient underwent spinal anaesthesia with 10 mg bupivacaine 0.5% in sitting position (the needle which was used was the Quincke No 27). The needle was withdrawn 0.5 -1 cm
Prevention
Placebo
Intervention: patient underwent spinal anaesthesia with 10 mg bupivacaine 0.5% in sitting position (the needle which was used was the Quincke No 27). The needle was withdrawn 0.5 -1 cm while barbotagi
Control: patient underwent spinal anaesthesia with 10 mg bupivacaine 0.5% in sitting position (the needle which was used was the Quincke No 27). The needle was withdrawn 0.5 -1 cm while barbotaging wa
Sponsors
Tehran university of medical sciences
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1-All patient candidate for spinal anesthesia; 2- age 18-40; 3-ASA class I & II. Exclusion criteria: 1- Migraine headache; 2-CNS malignancy; 3-Epilepsy; 4-systemic disease: HTN, cardiac arrhythmia, thyroid disease; 5- Psychiatric disorders; 6-Drug abuse; 7-Back pain.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Headache. Timepoint: 24 hours, 48 hours, 7 days. Method of measurement: classification of Severity of Meningeal Puncture Headache (MPH). | — |
Secondary
| Measure | Time frame |
|---|---|
| Backpain. Timepoint: 24 hours, 48 hours, 7 days. Method of measurement: Patient complaint. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Sara Emami
Tehran University of medical sciences
Outcome results
None listed